Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Intervention	STARTED	Sunitinib Followed by Everolimus	14
First Intervention	STARTED	Everolimus Followed by Sunitinib	2
First Intervention	COMPLETED	Sunitinib Followed by Everolimus	13
First Intervention	COMPLETED	Everolimus Followed by Sunitinib	2
First Intervention	NOT COMPLETED	Sunitinib Followed by Everolimus	1
First Intervention	NOT COMPLETED	Everolimus Followed by Sunitinib	0
Second Intervention	STARTED	Sunitinib Followed by Everolimus	13
Second Intervention	STARTED	Everolimus Followed by Sunitinib	2
Second Intervention	COMPLETED	Sunitinib Followed by Everolimus	9
Second Intervention	COMPLETED	Everolimus Followed by Sunitinib	1
Second Intervention	NOT COMPLETED	Sunitinib Followed by Everolimus	4
Second Intervention	NOT COMPLETED	Everolimus Followed by Sunitinib	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02315625/flow